We thank Leung et al for the interest
in our recent article. [1] There is a conceptual
difference between stroke and infarct. In our article and other
studies, [3,4] ischemic stroke was diagnosed according to the clinical
definition: an acute onset of a focal neurologic deficit lasting 24
hours or more specifically attributable to a cerebrovascular distribution.
In our
series, 6 of 169 patients developed procedure-related ischemic stroke
which was diagnosed by an experienced stroke neurologist. One stroke was related to a
new cortical infarct distal to the target lesion that was categorized as
embolic stroke. The other five ischemic strokes were accordant with diagnosis
of perforator stroke.
The rate of perforator stroke (3.0%) in our
report may not be underestimated. However, infarct is a diagnosis on the
basis of the neuroimaging and some of infarcts may be clinically silent. We mentioned that the lack of postoperative MRI may have
underestimated the number and size of perforator infarcts [1] instead of
perforator stroke.
Submaximal balloon dilatation and the use of the Wingspan stent (a self-
expanding intracranial stent not currently available in mainland China) may be theoretically be helpful in reducing the risk of perforator occlusion. [2]
This inference needs to be confirmed in a large
case series as perforator stroke did not occur in our initial 40
patients with middle cerebral arterial stenosis treated with balloon-expandable stent [5] but does occur with increasing cases. [1]
As Leung et al mention, whether the sustained radial force of the self-expanding stent can lead to
subacute occlusion of the perforating arteries also needs be confirmed in large case series. Nevertheless,
treatment with the Wingspan stent does have some advantages over the balloon-expandable steel stent including that patients can undergo MRI examination.
Postoperative MRI such as
diffusion-weighted or fluid attenuated inversion recovery imaging can
increase detection of acute or subacute perforator infarct and therefore
can improve the estimation accuracy of the perforator infarct rate
resulting from stenting.
References
3. Chimowitz MI, Lynn MJ, Howlett-Smith H, et al. Comparison of warfarin and aspirin for symptomatic intracranial
arterial stenosis. N Engl J Med. 2005; 352:1305¨C1316.
4. Kasner SE, Chimowitz MI, Lynn MJ et al on behalf of the Warfarin Aspirin Symptomatic Intracranial Disease
Trial Investigators. Predictors of ischemic stroke in the territory of a
symptomatic intracranial arterial stenosis. Circulation; 2006;113:555-563.
5. Jiang WJ, Wang YJ, Du B, et al. Stenting of symptomatic M1 stenosis of
middle cerebral artery: an initial experience of 40 patients. Stroke 2004;
35:1375.
Disclosure: The authors report no conflicts of interest.